CME Quote, Financials, Valuation and Earnings

Coinbase Global has a net margin of 58.22% compared to CME Group's net margin of 56.84%. CME Group's return on equity of 13.28% beat Coinbase Global's return on equity of 30.9%.

CME Group has a consensus price target of $270.35, signalling upside risk potential of 1.52%. On the other hand Coinbase Global has an analysts' consensus of $277.59 which suggests that it could grow by 32.41%. Given that Coinbase Global has higher upside potential than CME Group, analysts believe Coinbase Global is more attractive than CME Group.

CME Group has a beta of 0.427, which suggesting that the stock is 57.303% less volatile than S&P 500. In comparison Coinbase Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.94%. Coinbase Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CME Group pays 101.66% of its earnings as a dividend. Coinbase Global pays out -- of its earnings as a dividend.

CME Group quarterly revenues are $1.6B, which are smaller than Coinbase Global quarterly revenues of $2.3B. CME Group's net income of $956.2M is lower than Coinbase Global's net income of $1.3B. Notably, CME Group's price-to-earnings ratio is 26.79x while Coinbase Global's PE ratio is 22.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.26x versus 8.62x for Coinbase Global. Usually stocks with elevated PS ratios are considered overvalued.

Intercontinental Exchange has a net margin of 58.22% compared to CME Group's net margin of 23.04%. CME Group's return on equity of 13.28% beat Intercontinental Exchange's return on equity of 10.29%.

CME Group has a consensus price target of $270.35, signalling upside risk potential of 1.52%. On the other hand Intercontinental Exchange has an analysts' consensus of $187.31 which suggests that it could grow by 14.75%. Given that Intercontinental Exchange has higher upside potential than CME Group, analysts believe Intercontinental Exchange is more attractive than CME Group.

CME Group has a beta of 0.427, which suggesting that the stock is 57.303% less volatile than S&P 500. In comparison Intercontinental Exchange has a beta of 1.094, suggesting its more volatile than the S&P 500 by 9.398%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.94%. Intercontinental Exchange offers a yield of 1.12% to investors and pays a quarterly dividend of $0.48 per share. CME Group pays 101.66% of its earnings as a dividend. Intercontinental Exchange pays out 37.73% of its earnings as a dividend. Intercontinental Exchange's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than Intercontinental Exchange quarterly revenues of $3B. CME Group's net income of $956.2M is higher than Intercontinental Exchange's net income of $698M. Notably, CME Group's price-to-earnings ratio is 26.79x while Intercontinental Exchange's PE ratio is 34.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.26x versus 7.99x for Intercontinental Exchange. Usually stocks with elevated PS ratios are considered overvalued.

Nasdaq has a net margin of 58.22% compared to CME Group's net margin of 18.9%. CME Group's return on equity of 13.28% beat Nasdaq's return on equity of 11.5%.

CME Group has a consensus price target of $270.35, signalling upside risk potential of 1.52%. On the other hand Nasdaq has an analysts' consensus of $83.72 which suggests that it could grow by 11.1%. Given that Nasdaq has higher upside potential than CME Group, analysts believe Nasdaq is more attractive than CME Group.

CME Group has a beta of 0.427, which suggesting that the stock is 57.303% less volatile than S&P 500. In comparison Nasdaq has a beta of 1.021, suggesting its more volatile than the S&P 500 by 2.075%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.94%. Nasdaq offers a yield of 1.27% to investors and pays a quarterly dividend of $0.24 per share. CME Group pays 101.66% of its earnings as a dividend. Nasdaq pays out 48.43% of its earnings as a dividend. Nasdaq's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than Nasdaq quarterly revenues of $2.1B. CME Group's net income of $956.2M is higher than Nasdaq's net income of $395M. Notably, CME Group's price-to-earnings ratio is 26.79x while Nasdaq's PE ratio is 34.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.26x versus 5.59x for Nasdaq. Usually stocks with elevated PS ratios are considered overvalued.

S&P Global has a net margin of 58.22% compared to CME Group's net margin of 24.5%. CME Group's return on equity of 13.28% beat S&P Global's return on equity of 10.07%.

CME Group has a consensus price target of $270.35, signalling upside risk potential of 1.52%. On the other hand S&P Global has an analysts' consensus of $581.82 which suggests that it could grow by 21.21%. Given that S&P Global has higher upside potential than CME Group, analysts believe S&P Global is more attractive than CME Group.

CME Group has a beta of 0.427, which suggesting that the stock is 57.303% less volatile than S&P 500. In comparison S&P Global has a beta of 1.262, suggesting its more volatile than the S&P 500 by 26.168%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.94%. S&P Global offers a yield of 0.77% to investors and pays a quarterly dividend of $0.96 per share. CME Group pays 101.66% of its earnings as a dividend. S&P Global pays out 29.44% of its earnings as a dividend. S&P Global's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than S&P Global quarterly revenues of $3.6B. CME Group's net income of $956.2M is higher than S&P Global's net income of $880M. Notably, CME Group's price-to-earnings ratio is 26.79x while S&P Global's PE ratio is 38.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.26x versus 10.54x for S&P Global. Usually stocks with elevated PS ratios are considered overvalued.